Status:
COMPLETED
Evaluation of Patient's Knowledge of Their NACO Treatment
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Anticoagulant
Eligibility:
All Genders
18+ years
Brief Summary
More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant . The aim is to evaluate the pati...
Eligibility Criteria
Inclusion
- patient with AOD treatment
- capable to answer to questionnaire
- with or without antivitamin K
Exclusion
- dementia
- cognitive trouble
- refusing participation
Key Trial Info
Start Date :
December 5 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03323320
Start Date
December 5 2016
End Date
November 1 2017
Last Update
February 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France, 75014